| Title |
Author |
Type |
Date |
Words |
| Strategic consulting, design and implementation of an information and awareness campaign for the recruitment of participants in anti-HIV vaccine trials conducted by the Vaccine Research Institute. |
|
|
May 15, 2013 |
101 |
| Risk of nevirapine-associated Stevens-Johnson syndrome among HIV-infected pregnant women: the Medunsa National Pharmacovigilance Centre, 2007-2012. |
Dube, N.; Adewusi, E.; Summers, R. |
|
May 1, 2013 |
3089 |
| Anti-HIV therapy appears to protect children's hearts, NIH network study shows. |
|
|
Apr 22, 2013 |
107 |
| Frost & Sullivan: New Drug Candidates Hold Tremendous Promise for European HIV Drugs Market. |
|
|
Apr 17, 2013 |
721 |
| Frost & Sullivan: New Drug Candidates Hold Tremendous Promise for European HIV Drugs Market. |
|
|
Apr 17, 2013 |
726 |
| Critical AIDS medications: to Africa for the US Government. |
Larson, Chris |
|
Apr 1, 2013 |
1704 |
| Funding For AIDS Drugs Not Included In Senate Spending Bill. |
|
|
Mar 19, 2013 |
555 |
| Doctors in the US cure baby of HIV. |
|
|
Mar 7, 2013 |
420 |
| Doctors in the US cure baby of HIV. |
|
|
Mar 5, 2013 |
420 |
| AHF Demands FDA Reversal on Use of Gilead's HIV Prevention Pill for Women. |
|
|
Mar 5, 2013 |
604 |
| Doctors in the US cure baby of HIV. |
|
|
Mar 4, 2013 |
420 |
| Research and Markets: Nevirapine - Comprehensive 2013 Patent Search. |
|
|
Feb 18, 2013 |
441 |
| AHF Challenges Gilead over AIDS Drug Price Gouging of U.S. Gov't Programs on 'Stribild'. |
|
|
Jan 30, 2013 |
600 |
| Study on Generic HIV Meds Prompts AHF to Demand Gilead Cut ARV Prices. |
|
|
Jan 16, 2013 |
685 |
| AHF Blasts Gilead Price Hike on Four Key AIDS Drugs. |
|
|
Jan 10, 2013 |
838 |
| Event 300mg tablet tenofovir 38-2012. In response to amparo 01020-2010-00042. |
|
|
Jan 10, 2013 |
108 |
| AIDS drugs cut SA's maternal death rate. |
Bateman, Chris |
|
Jan 1, 2013 |
376 |
| HIV drug 'may help defuse deadly staph infections'. |
|
|
Dec 15, 2012 |
633 |
| Nigeria : MSD offers a new treatment for HIV in NIGERIA. |
|
|
Dec 6, 2012 |
237 |
| AHF: Corporate Welfare Spurs Gilead's Record Profits on AIDS Drugs. |
|
|
Dec 4, 2012 |
643 |
| Nevirapine for PMTCT in immuno-competent pregnant women--a warning. |
Seggie, Janet |
Brief article |
Nov 1, 2012 |
103 |
| Safety of nevirapine in HIV-infected pregnant women initiating antiretroviral therapy at higher CD4 counts: A systematic review and meta-analysis. |
Bera, Ebrahim; Mia, Rafiq |
Report |
Nov 1, 2012 |
4701 |
| AHF: Gilead Scores Record Profits on AIDS Drug Price Gouging. |
|
Financial report |
Oct 25, 2012 |
677 |
| Cruel Joke: AIDS-Plagued Tanzania Must Also Cope With Fake HIV Drugs. |
|
|
Oct 12, 2012 |
614 |
| Neutron Crystallography Aids Drug Design. |
|
|
Oct 9, 2012 |
599 |
| AHF: Texas and Louisiana Medicaid Not Yet Covering Gilead's Pricey AIDS Drug, Stribild. |
|
|
Oct 8, 2012 |
1136 |
| HIV Drug Efavirenz May Cause Memory Decline. |
|
|
Sep 29, 2012 |
347 |
| Common HIV drug may damage brain and lead to memory decline. |
|
|
Sep 28, 2012 |
613 |
| AHF: Gilead's Stribild Not Covered by NY Medicaid; State Also Explores 'Prior Auth' Status for AIDS Drug. |
|
|
Sep 24, 2012 |
756 |
| Research and Markets: Global HIV Drug Pipeline Capsule - 2012 Update. |
|
|
Sep 19, 2012 |
293 |
| AHF: Gilead Must Offer ADAP AIDS Drug Price Cut to Medicaid, Medicare. |
|
|
Sep 18, 2012 |
1123 |
| HIV treatment-naive option okayed. |
|
|
Sep 15, 2012 |
116 |
| United States : New Common Application for HIV/AIDS Medicines Available Through Johnson & Johnson Patient Assistance Foundation, Inc. |
|
|
Sep 13, 2012 |
383 |
| New Common Application for HIV/AIDS Medicines Available Through Johnson & Johnson Patient Assistance Foundation, Inc. |
|
|
Sep 12, 2012 |
548 |
| Anti-HIV vaginal ring can prevent virus transmission. |
|
|
Sep 6, 2012 |
472 |
| AHF Supports Price Cut on New AIDS Drug, Prods Gilead to Expand Cut to Other Programs. |
|
|
Sep 6, 2012 |
994 |
| New computer model offers 'realistic' tool to predict HIV drug resistance. |
|
|
Sep 3, 2012 |
415 |
| Protease inhibitors and stomach acid drugs linked to fractures in HIV+ veterans. |
|
|
Sep 1, 2012 |
1443 |
| Research and Markets: Lopinavir - Comprehensive Patent Search. |
|
|
Aug 31, 2012 |
446 |
| United States : FDA approves new combination pill for HIV treatment for some patients. |
|
|
Aug 28, 2012 |
414 |
| AHF: As Gilead Prepares to Price the 'Quad,' 20 California Legislators Say Aids Drug Pricing "Unsustainable". |
|
|
Aug 18, 2012 |
996 |
| AHF Lauds Rep. Alcee Hastings (D, FL) for Congressional Letter Cautioning Gilead on Pricing of New AIDS Drug. |
|
|
Aug 14, 2012 |
1483 |
| Ranbaxy, Gilead Sciences ink in-licensing pact to promote access to less costly HIV drugs. |
|
|
Aug 3, 2012 |
315 |
| SA patent law blocking vital second-line HIV drugs. |
Bateman, Chris |
|
Aug 1, 2012 |
354 |
| Truvada approved for HIV prevention. |
|
|
Aug 1, 2012 |
333 |
| United States : MERCK inks two licensing agreements for HIV drug candidates. |
|
|
Jul 27, 2012 |
155 |
| Gilead's Boosting Agent Cobicistat for HIV Therapy as Effective as Ritonavir in Pivotal Phase 3 Study. |
|
Clinical report |
Jul 24, 2012 |
1639 |
| Anti-HIV drugs 'may pass to baby in womb and during breast-feeding'. |
|
|
Jul 22, 2012 |
682 |
| HarborPath Creates a Single Portal for Uninsured Individuals to Access HIV/AIDS Medications. |
|
|
Jul 19, 2012 |
1207 |
| Obama Administration Touts Delayed Release of AIDS Drug Funds, Says AHF. |
|
|
Jul 19, 2012 |
452 |
| Research and Markets: Generics in the Antivirals Market to 2018 - Launch of Generic Combivir and Patent Expiry of Sustiva, Kaletra and Epivir-HBV will Drive Volume Growth. |
|
|
Jul 12, 2012 |
366 |
| AHF: Gilead's "Me Too" Quad AIDS Drug Offers Little Improvement, More Kidney Damage. |
|
|
Jul 6, 2012 |
1276 |
| AHF: CA State Treasurer Lockyer Urges Gilead to Show Restraint Pricing New AIDS Drug the 'Quad'. |
|
|
Jun 27, 2012 |
930 |
| Adding nevirapine to HIV regimen halves newborn transmission rate. |
|
Brief article |
Jun 21, 2012 |
105 |
| Ohio: AIDS Patients Win Another Round against State's Illegal Restrictions on AIDS Drug Access, Says AHF. |
|
|
Jun 12, 2012 |
1163 |
| AIDS Advocates to Gilead: Save More Lives, Price the "Quad" Reasonably. |
|
|
Jun 11, 2012 |
1199 |
| Enamine, MRC LMB and IOCB Announce Collaboration to Identify Novel Rhomboid Protease Inhibitors for Treatment of Various Diseases. |
|
|
Jun 6, 2012 |
506 |
| One Year Post-Launch, The Protease Inhibitors, Incivek and Victrelis have Collectively Penetrated Over Three-Quarters of the US Genotype 1 HCV Market. |
|
|
Jun 6, 2012 |
786 |
| Approaches to tenofovir and abacavir drug shortages in South Africa: a guide for clinicians. |
Schowalter, Laurie; Conradie, Francesca |
|
Jun 1, 2012 |
816 |
| Mylan Launches Generic Version of Viramune Tablets. |
|
|
May 23, 2012 |
468 |
| Since Gaining European Authority Approval for Victrelis in July and Incivo in September, Protease Inhibitor Share Has Penetrated Nearly One-Third of the Genotype 1 Market and is Anticipated to Significantly Increase Over the Next Six Months. |
|
|
May 21, 2012 |
690 |
| Anti-HIV drug tenofovir 'safe to take during pregnancy'. |
|
Medical condition overview |
May 16, 2012 |
428 |
| Research and Markets: Hepatitis C Virus - Protease Inhibitors Bring Change in the Treatment Paradigm for Hepatitis C Virus Infection - What Next? |
|
|
May 3, 2012 |
375 |
| Anti-HIV drug use during pregnancy does not affect infant size, birth weight. |
|
|
May 1, 2012 |
124 |
| AHF: AIDS Patients Protest, Testify Against Ohio Plan to Ration AIDS Drugs. |
|
|
Apr 5, 2012 |
1112 |
| Why it's time to say goodbye to stavudine ... everywhere. |
Andrieux-Meyer, Isabelle; Clayden, Polly; Collins, Simon; Geffen, Nathan; Goemaere, Eric; Harrington |
Report |
Mar 1, 2012 |
2876 |
| Low-dose stavudine trials: a public health priority for developing countries. |
Venter, W.D. Francois; Innes, Steve; Cotton, Mark |
Report |
Mar 1, 2012 |
2153 |
| Safety, strength and simplicity of efavirenz in pregnancy. |
Pillay, Prinitha; Black, Vivian |
Report |
Mar 1, 2012 |
6047 |
| AHF Challenges FDA Move to Fast Track Gilead's 'HIV Prevention' Drug Linked to Kidney Disease. |
|
|
Feb 16, 2012 |
680 |
| Research and Markets: Global HIV Drugs Market 2010-2014 Report - The Global HIV Drugs Market to Reach US$15.5 Billion By 2014. |
|
|
Feb 14, 2012 |
404 |
| Nevirapine and co-trimoxazole prophylaxis safe in HIV-exposed, uninfected infants. |
|
|
Feb 1, 2012 |
1017 |
| Vitamin D may improve bone health in those taking anti-HIV drug. |
|
Brief article |
Jan 10, 2012 |
104 |
| Research and Markets: Global HIV Drug Pipeline Capsule 2012: highlighting key research and development activities across the globe. |
|
|
Jan 10, 2012 |
390 |
| SQU team to study genetic factors in AIDS treatment. |
|
|
Jan 2, 2012 |
873 |
| Raltegravir-based HIV therapy bests efavirenz. |
Mahoney, Diana |
|
Jan 1, 2012 |
599 |
| Merck and the ADAP Crisis Task Force Announce New Agreement to Improve Access and Care for People with HIV. |
|
|
Dec 21, 2011 |
2131 |
| FDA Expands Use of HIV Drug Isentress to Children and Adolescents. |
|
|
Dec 21, 2011 |
717 |
| AHF Salutes Merck for AIDS Drug Price Cuts for Hard-Hit Programs. |
|
|
Dec 21, 2011 |
983 |
| AHF Slams Gilead "HIV Prevention Pill" FDA Application. |
|
|
Dec 16, 2011 |
1097 |
| AHF Targets Merck Over AIDS Drug Pricing. |
|
|
Dec 8, 2011 |
670 |
| AHF Praises J&J for AIDS Drug Price Cut, Asks Merck to Follow Suit. |
|
|
Dec 8, 2011 |
672 |
| AHF Salutes Gilead on Price Cuts for US AIDS Drug Program. |
|
|
Dec 5, 2011 |
1077 |
| Why should we still care about the stavudine dose? |
Innes, Steve; Cotton, Mark; Venter, Francois |
Viewpoint essay |
Dec 1, 2011 |
1519 |
| AHF to Stage "Occupy Gilead" Protest Over Gilead's AIDS Drug Prices. |
|
|
Nov 30, 2011 |
1286 |
| Vioxx: Merck Continues Bad Behavior With AIDS Drug Pricing, Says AHF. |
|
|
Nov 23, 2011 |
546 |
| Research and Markets: The HIV Drugs Market in India to Reach US$54 Million by 2014 According To Recent Report. |
|
|
Nov 21, 2011 |
385 |
| UN Reports Death and Infections Down Due to AIDS Drugs - Funding Must Go Up, Says AHF. |
|
|
Nov 21, 2011 |
595 |
| AHF to Stage "Day of the Dead" Funeral Procession to Protest Gilead's AIDS Drug Prices. |
|
|
Nov 2, 2011 |
1544 |
| HIV testing update. |
Cohen, Jenny K.; Klausner, Jeffrey D. |
Report |
Nov 1, 2011 |
5418 |
| Over the Next Decade, the Dominance of Bristol-Myers Squibb/Gilead's Atripla in the HIV Drug Market Will Be Challenged by Gilead's Quad and Gilead/Janssen's Complera. |
|
|
Oct 27, 2011 |
629 |
| NIH researchers show how anti-HIV drug acts to block herpes virus. |
|
Brief article |
Oct 20, 2011 |
105 |
| Merck's ISENTRESS[R] (raltegravir) in Combination Therapy Demonstrated Virological and Immunological Efficacy Versus the Efavirenz Regimen at 192 Weeks of Treatment in Previously Untreated Adults with HIV-1. |
|
|
Oct 13, 2011 |
5798 |
| AHF: Global Fund Rejects Request To End U.S. AIDS Drug Crisis. |
|
|
Oct 13, 2011 |
509 |
| Hepatitis C Landscape is Changing as the New Protease Inhibitors are Adopted into Clinical Practice. |
|
|
Oct 6, 2011 |
736 |
| Over 380,000 Malawians on free HIV drugs: officials. |
|
|
Oct 5, 2011 |
183 |
| AHF Hosts NJ Protest & 'Die-In' over J&J's AIDS Drug Prices--September 30th. |
|
|
Sep 30, 2011 |
1242 |
| AHF Sues FDA over Information on Gilead's HIV Prevention Pill. |
|
|
Sep 23, 2011 |
972 |
| AHF Requests $50M Help from Global Fund, Warren Buffett to End AIDS Drug Crisis in US. |
|
|
Sep 15, 2011 |
1682 |
| Open Letter From HIV-Positive Prevention Advocates Rejects Misinformation About Pre-Exposure Prophylaxis (PrEP). |
|
|
Sep 15, 2011 |
948 |
| AHF Hosts Third "Die-in" Protest Over Gilead's AIDS Drug Prices. |
|
|
Sep 13, 2011 |
1457 |
| AIDS Advocates to J & J: 'AIDS Drug Prices to Die For!'; Sept. 9th Protest, New Brunswick, NJ--12:30pm. |
|
|
Sep 9, 2011 |
1163 |
| AHF Spearheads 'Pill Bottle Protest' Over Gilead's AIDS Drug Prices. |
|
|
Aug 31, 2011 |
1040 |
| Gilead PrEP Campaign Leads to Truvada Black Market in Florida, AHF Says. |
|
|
Aug 19, 2011 |
935 |
| AHF Stages Second "Die-in" & Protest Over Gilead's AIDS Drug Prices. |
|
|
Aug 18, 2011 |
818 |
| AHF Hosts NJ Protest & 'Die-In' Over J&J's AIDS Drug Prices--August 17th Noon. |
|
|
Aug 16, 2011 |
1328 |
| SOUTH AFRICA : South Africa to offer better provision of anti-AIDS drugs. |
|
|
Aug 16, 2011 |
230 |
| NanoViricides Reports HIVCide Exhibited Long Term Sustained Anti-HIV Effects Even After Drug Discontinuation. |
|
|
Aug 15, 2011 |
1308 |
| Why some HIV cocktails pack a bigger punch: steep dose-response curves explain drugs' characteristics. |
Ehrenberg, Rachel |
|
Aug 13, 2011 |
765 |
| AHF: Gilead's Pricing of Complera May Break Hard-Hit AIDS Drug Programs. |
|
|
Aug 11, 2011 |
860 |
| AHF: Sen. Rubio (R, FL) Offers Obama Administration Proposal to End Growing AIDS Drug Crisis. |
|
|
Aug 8, 2011 |
858 |
| AHF Hosts Protest & "Die-in" Over Gilead's AIDS Drug Prices. |
|
|
Aug 3, 2011 |
1523 |
| AHF: Victory! Boehringer Ingelheim to Increase AIDS Drug Program Rebates. |
|
|
Aug 3, 2011 |
670 |
| AHF: AIDS Protesters to Merck: 'Do the Right Thing!' on Drug Prices -- NJ Protest, July 28th. |
|
|
Jul 27, 2011 |
1763 |
| AHF: AIDS Protesters to J & J: 'No More Tears!' on AIDS Drug Pricing--July 27th NJ Protest. |
|
|
Jul 26, 2011 |
1564 |
| NanoViricides Reports Anti-HIV Efficacy Equivalent to HAART Drug Cocktail Treatment in Animal Study, Successfully Advancing its HIVCide Lead Optimization Program. |
|
Report |
Jul 25, 2011 |
1477 |
| Obama Administration Decision May Force Florida to Pull AIDS Medications from Existing Patients. |
|
|
Jul 25, 2011 |
536 |
| In the Real Life Setting, Boosted REYATAZ (atazanavir/ritonavir) Proves as Effective in Women Living with HIV as Men. |
|
Clinical report |
Jul 20, 2011 |
1172 |
| VICTRELIS[TM] (boceprevir), First-in-Class Oral Hepatitis C Virus Protease Inhibitor, Approved in the European Union for Treatment of Chronic Hepatitis C. |
|
|
Jul 18, 2011 |
2148 |
| Ranbaxy,Gilead Sciences to manufacture and market three anti-HIV drugs in India, developing nations. |
|
|
Jul 14, 2011 |
339 |
| AHF to Protest Bay Area's Gilead Sciences over AIDS Drug Pricing at SF's Fed Building. |
|
|
Jul 13, 2011 |
1363 |
| HIV Drugs Reduce Transmission Risk for Heterosexual Couples. |
|
|
Jul 13, 2011 |
520 |
| Anti-HIV Drugs Prevent Infection in Healthy Heterosexuals, An End to the HIV Epidemic? |
|
|
Jul 13, 2011 |
317 |
| AHF Lauds Gilead as First to Share AIDS Drug Patents with New Global Patent Pool. |
|
|
Jul 12, 2011 |
507 |
| Doctors to FDA: "HIV Prevention Pill" Not Ready for Approval. |
|
|
Jun 29, 2011 |
1155 |
| AHF Challenges Gilead over AIDS Drug Pricing During Protest at Foster City HQ. |
|
|
Jun 29, 2011 |
880 |
| Atlanta TONIGHT: Rep. John Lewis to Appear at AIDS Drug Crisis Town Hall. |
|
|
Jun 28, 2011 |
1130 |
| HIV drugs linked to premature aging. |
|
|
Jun 27, 2011 |
118 |
| AIDS Advocates to Rally at Ohio Statehouse Over AIDS Drug Crisis. |
|
|
Jun 13, 2011 |
869 |
| Massive Opportunity Exists in Hepatitis C Market for Recently Approved Protease Inhibitors Victrelis and Incivek According to a New Report by BioTrends Research Group. |
|
|
Jun 13, 2011 |
555 |
| AHF Slams Feds for Pressing Florida to Cut Eligibility for Lifesaving AIDS Drug Program. |
|
|
Jun 10, 2011 |
986 |
| Underutilization of the AIDS drug assistance program: associated factors and policy implications. |
Godwin, Noah C.; Willig, James H.; Nevin, Christa R.; Lin, Hui-Yi; Allison, Jeroan; Gaddis, Kathy; P |
Clinical report |
Jun 1, 2011 |
4867 |
| Research and Markets: HIV - Better Differential Pricing Strategies are Needed to Ensure Access to HIV Drugs. |
|
|
Jun 1, 2011 |
376 |
| Longer anti-HIV therapy is worth the cost. |
Rosenberg, Jared |
|
Jun 1, 2011 |
408 |
| Research and Markets: Telaprevir and Boceprevir: The First Generation Protease Inhibitors Boosts Response Rates to Standard Chronic Hepatitis C Treatment. |
|
|
May 31, 2011 |
328 |
| FDA Approves New HIV Treatment. |
|
|
May 20, 2011 |
727 |
| Protease inhibitors poised to improve HCV outcomes. |
Mechcatie, Elizabeth |
|
May 15, 2011 |
554 |
| FDA Approves Merck's VICTRELIS(TM) (boceprevir), First-in-Class Oral Hepatitis C Virus (HCV) Protease Inhibitor. |
|
|
May 14, 2011 |
4124 |
| FDA Approves Merck's VICTRELIS[TM] (boceprevir), First-in-Class Oral Hepatitis C Virus (HCV) Protease Inhibitor. |
|
|
May 13, 2011 |
4039 |
| Traces of Fungicide Found in HIV Drug. |
|
|
May 12, 2011 |
365 |
| HIV drugs can also kill malaria parasites: Study. |
|
|
May 3, 2011 |
166 |
| AHF's Board Opposes FDA-approval of Gilead's AIDS Drug Truvada as HIV Prevention. |
|
|
May 3, 2011 |
855 |
| Prevalence of drug-resistant mutations in newly diagnosed drug-naive HIV-1-infected individuals in a treatment site in the Waterberg district, Limpopo province. |
Nwobegahay, Julius; Bessong, Pascal; Masebe, Tracy; Mavhandu, Lufuno; Manhaeve, Cecile; Ndjeka, Norb |
Report |
May 1, 2011 |
2070 |
| Post-natal ARV prophylaxis for infants: efficacy of extended nevirapine. |
|
Brief article |
May 1, 2011 |
272 |
| AHF to Question Abbott on AIDS Drug Pricing During April 29 AGM in Abbott Park. |
|
|
Apr 29, 2011 |
787 |
| AHF: Gilead Must Halt FDA Approval of Truvada as HIV Prevention After PrEP Study in Women Fails. |
|
|
Apr 18, 2011 |
875 |
| CA Treasurer Seeks AIDS Drug Price Cuts from Gilead, Others. |
|
|
Apr 11, 2011 |
1038 |
| FDA Approves One-Pill, Once-Daily Viramune XR(TM) (nevirapine) Extended-Release Tablets for Use in Combination With Other Antiretroviral Agents for Treatment of HIV-1 Infection in Adults. |
|
|
Apr 4, 2011 |
2070 |
| The risks of concurrent treatment with tenofovir and aminoglycosides in patients with HIV-associated tuberculosis. |
Kenyon, Chris; Wearne, Nicci; Burton, Rosie; Meintjes, Graeme |
Case study |
Apr 1, 2011 |
2385 |
| PHPT-3 trial. |
|
Report |
Apr 1, 2011 |
520 |
| AHF: CA Controller Chiang Urges AIDS Drug Price Cut from Merck, Tibotec & ViiV. |
|
|
Mar 31, 2011 |
1009 |
| AHF: CA Controller Chiang Urges AIDS Drug Price Cut from Abbott, BI, BMS & Genentech. |
|
|
Mar 30, 2011 |
1032 |
| ActiveSite Pharmaceuticals' Small Molecule Protease Inhibitor Blocks Retinal Blood Vessel Damage in Rodent Model of Diabetes. |
|
|
Mar 28, 2011 |
505 |
| AHF: CA Controller Chiang Urges Gilead to Cut AIDS Drug Prices. |
|
|
Mar 25, 2011 |
991 |
| Testing, linking, retaining: an HIV clinician's perspective: an interview with Michael J. Mugavero, MD. |
Mascolini |
Interview |
Mar 22, 2011 |
4001 |
| Twenty years' working in HIV nursing: a personal journey. |
Bellingham, Catriona |
Essay |
Mar 22, 2011 |
2766 |
| AHF to Gilead: "No Magic Pill" Ads Warn against AIDS Drug as HIV Prevention. |
|
|
Mar 9, 2011 |
1910 |
| New HIV/AIDS study could turn treatment 'on its head'. |
|
|
Mar 5, 2011 |
502 |
| New drug regimens cut HIV spread from mother to infant. |
|
|
Mar 2, 2011 |
135 |
| AHF: Representative Hastings (D, FL) Ups AIDS Drug Budget by $42M. |
|
|
Feb 19, 2011 |
1322 |
| AHF: Obama FY12 Budget Continues Rationing on AIDS Drugs. |
|
|
Feb 18, 2011 |
954 |
| FDA Approves Labeling Update for REYATAZ[R] (atazanavir sulfate) Capsules to Include Data Supporting the Recommended Adult Dose of REYATAZ/ritonavir 300/100 mg for HIV-1 Infected Pregnant Women. |
|
|
Feb 7, 2011 |
2680 |
| AHF Seeks 20% Price Cut from AIDS Drug Companies for State Program. |
|
|
Feb 3, 2011 |
1105 |
| AHF Offers Alternatives to Rationing AIDS Drugs. |
|
|
Jan 20, 2011 |
1016 |
| AIDS Drug Maker Boehringer Ingelheim Refuses to Increase Access for Low-Income Patients. |
|
|
Jan 19, 2011 |
1068 |
| AHF: Florida Plan to Limit AIDS Drug Access Halted. |
|
|
Jan 7, 2011 |
1181 |
| Boceprevir, Merck's Investigational Oral Hepatitis C Protease Inhibitor, Receives FDA Priority Review and EMA Accelerated Assessment. |
|
|
Jan 6, 2011 |
767 |
| AHF Will Supply $1 Million in Free AIDS Drugs to Florida Wait List Patients. |
|
|
Jan 3, 2011 |
996 |
| Press Telecon: AHF Sues AIDS Drug Maker Johnson & Johnson/Tibotec Therapeutics for Overcharging. |
|
|
Dec 21, 2010 |
1160 |
| HIV drugs offer barrier to virus: antiretrovirals limit infection rate among men at high risk. |
Seppa, Nathan |
|
Dec 18, 2010 |
330 |
| Dec. 20th, Miami Town Hall: AIDS Advocates to Call on Sen. Nelson to Solve FL AIDS Drug Crisis. |
|
|
Dec 17, 2010 |
1525 |
| Researchers Find How HIV Eludes Treatment. |
|
|
Dec 16, 2010 |
321 |
| US Hoards $48B in Unobligated Health Funds as AIDS Drug Crisis Threatens Lives of Over 4,500 Americans, Says AHF. |
|
|
Dec 16, 2010 |
785 |
| How 'chameleon-like' HIV virus eludes treatment by mutating. |
|
|
Dec 16, 2010 |
230 |
| Australian Market Report of December 8, 2010: Aston Resources (ASX:AZT) and ITOCHU (TYO:8001) To Establish Maules Creek Coal Joint Venture. |
|
|
Dec 8, 2010 |
361 |
| Save Florida AIDS Patients! Save ADAP! Nov 30th Ft. Lauderdale Rally Targets Crisis in Florida's AIDS Drug Program. |
|
|
Nov 29, 2010 |
1213 |
| Zacks Analyst Blog Highlights: Gilead Sciences, Johnson & Johnson, Bristol-Myers Squibb, Parker Hannifin Corporation and Eaton Corporation. |
|
|
Nov 26, 2010 |
1200 |
| South Africa's 'Whoonga' craze: mixing HIV drugs with marijuana. |
|
|
Nov 23, 2010 |
248 |
| HIV drugs 'lead to insulin resistance'. |
|
|
Nov 23, 2010 |
229 |
| Study Finds New Target for HIV Drug Therapies. |
|
|
Nov 22, 2010 |
636 |
| Fight to give HIV drugs to newborn; COURTS 1. |
|
|
Nov 20, 2010 |
123 |
| New Long-Term Observational Study Shows Durable Viral Suppression of Boosted REYATAZ(R) (atazanavir/ritonavir)-Based Regimens in a Real-Life Setting in Treatment-Experienced HIV Patients. |
|
Clinical report |
Nov 9, 2010 |
572 |
| AHF Blasts Florida's 'Scorched Earth' Approach to AIDS Drug Crisis: State Abandons 350 Patients. |
|
|
Nov 3, 2010 |
1131 |
| Glaxo subpoenaed regarding Avandia, HIV drugs. |
|
Brief article |
Nov 2, 2010 |
284 |
| Developing Canada's research base for harm reduction and health equity approaches to HIV prevention and treatment. |
Shoveller, Jeannie; DeBeck, Kora; Montaner, Julio |
Report |
Nov 1, 2010 |
2637 |
| Owing Largely to the Generic Erosion of Key Antiretroviral Agents, Growth in the HIV Drug Market Will Decline to 2.2 Percent Annually From 2014 to 2019. |
|
|
Oct 27, 2010 |
741 |
| New Label Changes for Commonly Prescribed HIV Drug Invirase. |
|
|
Oct 21, 2010 |
650 |
| Silver lining seen in failed trial of anti-HIV gel. |
Smith, Jennie |
|
Oct 15, 2010 |
654 |
| HIV drug treatment doesn't reduce risk of partner infection. |
|
|
Oct 1, 2010 |
343 |
| Wednesday, Sept. 29th: AIDS Advocates to Protest Speaker Pelosi's Silence on AIDS Drug Crisis. |
|
|
Sep 28, 2010 |
1391 |
| Biomedical approaches to HIV prevention. |
Mayer, Kenneth H.; Skeer, Margie; Mimiaga, Matthew J. |
Report |
Sep 22, 2010 |
7385 |
| No gender-based difference in HIV treatment response. |
|
|
Sep 21, 2010 |
482 |
| How HIV resists AIDS preventing AZT drug. |
|
|
Sep 20, 2010 |
294 |
| Docs breach norms to prescribe costly AIDS drugs. |
|
|
Sep 15, 2010 |
450 |
| Four US medical workers arrested in Zimbabwe over AIDS drugs. |
|
|
Sep 12, 2010 |
310 |
| In utero tenofovir linked to low weight at 1 year. |
Zoler, Mitchel L. |
|
Sep 1, 2010 |
550 |
| FL: suit for breach of confidentiality dismissed: Dr. asks about HIV meds in childrens' presence. |
Tammelleo, A. David |
Case overview |
Sep 1, 2010 |
477 |
| AHF Offers Solution to End Florida's AIDS Drug Waiting List. |
|
|
Sep 1, 2010 |
1306 |
| A rare phenomenon of atypical lipodystrophy in a patient on HAART in the absence of a protease inhibitor regimen. |
Mitha, Mohammed; Cupido, Gordon; Taljaard, Jantjie |
Case study |
Sep 1, 2010 |
920 |
| Shift to generic HIV drugs increased access, saved money. |
Rosenberg, Jared |
Author abstract |
Sep 1, 2010 |
261 |
| Early start of HIV drug treatment saves lives. |
Rosenberg, Jared |
Report |
Sep 1, 2010 |
250 |
| FL Sen. Bill Nelson Tells Senate Leadership More Money Is Needed for Hard-hit AIDS Drug Program, Reports AHF. |
|
|
Aug 20, 2010 |
1191 |
| New approach for targeted killing of HIV virus. |
|
|
Aug 19, 2010 |
312 |
| Promising new HIV drug keeps virus out of cells. |
|
|
Aug 19, 2010 |
390 |
| Bristol-Myers Squibb and ADAP Crisis Task Force Announce Enhanced, Multi-year Support for AIDS Drug Assistance Programs (ADAPs) in the United States. |
|
|
Aug 11, 2010 |
1046 |
| BMS Yields on AIDS Drug Pricing Following Sustained AHF Advocacy Campaign, Says AHF. |
|
|
Aug 11, 2010 |
1553 |
| BMS to Yield on AIDS Drug Pricing following Sustained AHF Advocacy Campaign, Says AHF. |
|
|
Aug 5, 2010 |
1351 |
| NJ Avoids Deadly AIDS Drug Cuts While Local Drug Giant BMS Refuses to Cut Prices for ADAPs, Says AHF. |
|
|
Aug 3, 2010 |
744 |
| Experimental tenofovir vaginal gel stops HIV infection. |
Zoler, Mitchel L. |
Clinical report |
Aug 1, 2010 |
701 |
| CA Controller Chiang Urges BMS to Cut Price of AIDS Drug Reyataz, says AHF. |
|
|
Jul 27, 2010 |
999 |
| A vaginal gel containing Gilead Sciences Inc's (Foster City CA) AIDS drug Viread cut HIV infections by as much as 54% in a trial in South Africa, the first time such a product has protected women after six previous gels failed. |
|
|
Jul 26, 2010 |
385 |
| NIH-Funded Study Finds Early HAART during TB Treatment Boosts Survival Rate in People Co-Infected with HIV and TB. |
|
|
Jul 22, 2010 |
189 |
| Study Shows Once-Daily, Extended-Release Formulation of Nevirapine was not Inferior to Twice-Daily VIRAMUNE in Treatment-Naive HIV-1 Infected Patients. |
|
|
Jul 22, 2010 |
1521 |
| TOMORROW -- AIDS Advocates to Rally at Iowa Capitol Bldg. Over AIDS Drug Crisis. |
|
|
Jul 19, 2010 |
815 |
| AIDS gel medicine helps reduce infections. |
|
|
Jul 19, 2010 |
309 |
| Anti-AIDS gel helps prevent infection, study finds. |
|
|
Jul 19, 2010 |
501 |
| Photo of AHF-Led AIDS Drug Protest in Ft. Lauderdale Available on Business Wire's Web Site and AP PhotoExpress. |
|
|
Jul 16, 2010 |
164 |
| TOMORROW: AIDS Advocates to Protest at Federal Bldg to Save AIDS Drug Program. |
|
|
Jul 15, 2010 |
1356 |
| Statement from Secretary Sebelius on Reallocating $25 Million for AIDS Drug Assistance. |
|
|
Jul 9, 2010 |
348 |
| AHF Pops Obama Trial Balloon of $30M for Hard-Hit US AIDS Drug Assistance Program. |
|
|
Jun 25, 2010 |
350 |
| AIDS drugs block 99pc of HIV transmission to breastfed babies. |
|
|
Jun 17, 2010 |
203 |
| Idenix Pharmaceuticals Initiates Proof-of-Concept Study for Protease Inhibitor IDX320 in Hepatitis C Patients. |
|
|
Jun 10, 2010 |
1286 |
| NanoViricides Reports that Antiviral Efficacy was Demonstrated Against Two Different HIV-1 Isolates in Cell Culture Studies, Corroborating Previous Findings in Animal Studies. |
|
|
Jun 8, 2010 |
1063 |
| Gilead Sciences and ADAP Crisis Task Force Announce New Initiatives to Support AIDS Drug Assistance Programs (ADAPs). |
|
|
Jun 4, 2010 |
1232 |
| AHF Lauds Gilead for AIDS Drug Price Concessions for Nation's ADAPs. |
|
|
Jun 4, 2010 |
557 |
| AHF Advocacy Spurs AIDS Drug Companies to Yield on Pricing. |
|
|
Jun 3, 2010 |
1216 |
| HIV Tests Can Do More Harm Than Good. |
|
|
Jun 2, 2010 |
400 |
| Research and Markets: HIV Drugs - Global Strategic Business Report: Annual Estimates and Forecasts Are Provided for the Period 2006 Through 2015. |
|
Report |
May 25, 2010 |
337 |
| AHF to Obama: Solve US AIDS Drug Crisis Now. |
|
|
May 25, 2010 |
479 |
| Senate Bill by Coburn & Burr Takes Aim at AIDS Drug Crisis, Says AHF. |
|
|
May 24, 2010 |
366 |
| Vaginal gel could offer protection against HIV. |
|
|
May 24, 2010 |
455 |
| Gout treatment gets label update for HIV drug interaction. |
|
|
May 18, 2010 |
336 |
| NanoViricides Signs anti-HIV Drug Candidate Testing Agreement with University of California, San Francisco. |
|
|
May 17, 2010 |
812 |
| New, inexpensive pouch could reduce mother-to-infant HIV infection. |
|
|
May 15, 2010 |
278 |
| NYC Protest: AHF to Blast BMS on AIDS Drug Pricing at Bank of America Healthcare Conference. |
|
Conference news |
May 11, 2010 |
942 |
| Heinz Family Philanthropies, Welvista and Abbott Announce Solution to Help Patients on State ADAP Waiting Lists for No-Cost HIV Medications. |
|
|
May 7, 2010 |
878 |
| FDA Recommends New Dosing for Colcrys(R) (Colchicine, USP) when Co-Administered with Protease Inhibitors. |
|
|
May 6, 2010 |
1455 |
| AHF: Giant CA Pension Fund Expresses Concern about BMS' Pricing on Key AIDS Drug Reyataz. |
|
|
May 4, 2010 |
753 |
| AIDS Drug Company Price Cuts Validated By New Data, Says AHF. |
|
|
May 4, 2010 |
712 |
| Protease-inhibitor interactions--a structural insight. |
Laskar, Aparna; Mandal, C.N.; Chatterjee, Aniruddha |
|
May 1, 2010 |
8680 |
| Dysfunctional MCC under legal threat. |
Bateman, Chris |
|
May 1, 2010 |
1286 |
| HAART during pregnancy and breastfeeding in the developing world. |
|
|
May 1, 2010 |
491 |
| Pregnancy associated with hepatotoxicity regardless of nevirapine exposure, USA. |
|
Brief article |
May 1, 2010 |
198 |
| Research and Markets: HIV/AIDS - Drug Pipeline Analysis and Market Forecasts to 2016. |
|
|
Apr 28, 2010 |
508 |
| Abbott Receives FDA Approval for Once-Daily Dosing of Kaletra (R) (lopinavir / ritonavir) for Treatment-Experienced Patients. |
|
|
Apr 28, 2010 |
2038 |
| Victory! AHF Lauds Merck for Doubling ADAP AIDS Drug Rebates for Isentress. |
|
|
Apr 27, 2010 |
1294 |
| AIDS Drug Access Bill Clears Key Florida Legislative Committee, Notes AHF. |
|
|
Apr 12, 2010 |
1249 |
| AHF Presses BMS to Slash Price of Key AIDS Drug Reyataz. |
|
|
Apr 6, 2010 |
638 |
| Expected surge in HIV drug resistance. |
Currie, Donya |
|
Apr 1, 2010 |
204 |
| HIV drug pipeline diverting more agents to first-line use. |
Boschert, Sherry |
Report |
Apr 1, 2010 |
413 |
| Miami Protest: AHF to Blast Merck on AIDS Drug Pricing During Barclays Investor Conference. |
|
|
Mar 23, 2010 |
1347 |
| FDA announces possible safety concern for HIV drug combination. |
|
Brief article |
Mar 9, 2010 |
232 |
| Warning added for didanosine. |
|
|
Mar 1, 2010 |
188 |
| CA Pension Funds Express Concern Over Merck AIDS Drug Pricing, Says AHF. |
|
|
Mar 1, 2010 |
925 |
| HIV drug given to protect foetus should be avoided after childbirth for 1yr. |
|
|
Feb 26, 2010 |
270 |
| Increased HAART coverage tied to 50pc drop among injection drug users. |
|
|
Feb 22, 2010 |
238 |
| Merck Rattled by AIDS Banners in Hometown. |
|
|
Feb 16, 2010 |
981 |
| AHF: Merck's AIDS Drug Pricing Focus of S.F. Protest During Medical Conference at Moscone Center. |
|
|
Feb 16, 2010 |
1429 |
| Hope for better AIDS drug soars. |
|
|
Feb 3, 2010 |
279 |
| Breakthrough may lead to new HIV drugs. |
|
|
Feb 1, 2010 |
319 |
| Fake healers--DA concerned. |
Bateman, Chris |
Brief article |
Feb 1, 2010 |
210 |
| Merck Rewrites History on Pricing Top AIDS Drug, Isentress, Says AHF. |
|
|
Jan 21, 2010 |
1123 |
| AHF Blasts Merck on AIDS Drug Pricing During Investor Conference Protest in S.F. |
|
Conference news |
Jan 11, 2010 |
670 |
| Regional and temporal trends in migration among people living with HIV/AIDS in British Columbia, 1993-2005. |
Lima, Viviane D.; Druyts, Eric; Montaner, Julio S.G.; Hogg, Robert S. |
Report |
Jan 1, 2010 |
3479 |
| Start anti-HIV drugs earlier, new federal guidelines say. |
Boschert, Sherry |
Clinical report |
Jan 1, 2010 |
605 |
| Routine lab tests of toxic effects of HIV drugs can be safely scrapped: study. |
|
|
Dec 22, 2009 |
474 |
| Don't Slash AIDS Drugs, CA Assembly Members Tell Governor. |
|
|
Dec 18, 2009 |
466 |
| California's AIDS Drug Cuts 'Life or Death' for Patients. |
|
|
Dec 1, 2009 |
800 |
| Johnson & Johnson's (New Brunswick NJ) Tibotec Therapeutics unit won approval for its Intelence HIV drug designed to treat patients who have stopped responding to other treatments. |
|
Brief article |
Nov 30, 2009 |
119 |
| New HIV drug hope. |
|
|
Nov 30, 2009 |
91 |
| Maternal HAART cuts postnatal HIV transmission risk. |
|
|
Nov 28, 2009 |
229 |
| Concert Pharmaceuticals Initiates Phase 1b Clinical Trial of CTP-518, Protease Inhibitor for Treatment of HIV. |
|
|
Nov 9, 2009 |
740 |
| Promising candidates for new HIV drugs found. |
|
|
Oct 21, 2009 |
321 |
| New discovery may help create less toxic anti-HIV drugs. |
|
|
Oct 21, 2009 |
309 |
| Promising candidates for new HIV drugs found. |
|
|
Oct 18, 2009 |
321 |
| New discovery may help create less toxic anti-HIV drugs. |
|
|
Oct 18, 2009 |
309 |
| FDA committee recommends wider use of Selzentry. |
|
|
Oct 13, 2009 |
632 |
| Pfizer's Selzentry Poised To Be Most Expensive First-Line AIDS Drug. |
|
|
Oct 8, 2009 |
509 |
| FDA Marks 100th HIV/AIDS Drug Authorized for Purchase Under PEPFAR. |
|
|
Oct 6, 2009 |
700 |
| Avexa Closes ATC's Phase III Trial to Evaluate Data. |
|
|
Oct 2, 2009 |
547 |
| NanoViricides, Inc. Signs a Master Service Agreement with Southern Research Institute for further Influenza and HIV Studies. |
|
|
Sep 21, 2009 |
1043 |
| India says no to AIDS drug patents, reaffirms role as 'pharmacy' of poor countries. |
|
|
Sep 4, 2009 |
444 |
| AHF Challenges Merck's "Criminal AIDS Drug Pricing" for Isentress. |
|
|
Sep 3, 2009 |
858 |
| President Clinton, Pfizer, and Mylan Announce New Agreements to Lower Prices of Medicines for Patients with Drug-Resistant HIV in Developing Countries. |
|
|
Aug 6, 2009 |
1987 |
| HAART may help reduce mother-to-child HIV transmission. |
|
|
Aug 2, 2009 |
252 |
| AHF Renews Challenge to Merck on Price of AIDS Drug Isentress. |
|
|
Jul 24, 2009 |
806 |
| ISENTRESSA (raltegravir), from MSD, was as Effective as Efavirenz at. |
|
|
Jul 22, 2009 |
819 |
| Cavitation of the Ghon focus in an HIV-infected infant who acquired tuberculosis after the initiation of HAART. |
Innes, S.; Schaaf, H.S.; Cotton, M.F. |
|
Jun 22, 2009 |
1463 |
| Africa must make own AIDS drugs. |
Bateman, Chris |
Brief article |
May 1, 2009 |
265 |
| TWO pharmaceutical giants are to form; Business IN BRIEF. |
|
|
Apr 17, 2009 |
110 |
| AIDS Activists Claim Victory: Abbott Cuts Mexican Price of Kaletra 20%. |
|
|
Mar 26, 2009 |
1061 |
| HIV/TB: when is it safe to start HAART? |
Wood, Robin |
|
Mar 22, 2009 |
3251 |
| Changes in body composition and other anthropometric measures of female subjects on Highly Active Antiretroviral Therapy (HAART): a pilot study in Kwazulu-Natal, South Africa. |
Esposito, F.M.; Coutsoudis, A.; Visser, J.; Kindra G. |
Clinical report |
Mar 22, 2009 |
4638 |
| Avexa Reports Positive 96 Week Data for HIV Drug Apricitabine (ATC). |
|
|
Mar 16, 2009 |
918 |
| Ramsell Public Health Rx Unveils AIDS Drug Assistance Program (ADAP) Data Management System. |
|
|
Feb 9, 2009 |
549 |
| Research and Markets: Global HIV Market: New Analysis Discusses the Opportunities Prevailing in the HIV Drugs Market and Issues Affecting the Growth. |
|
Industry overview |
Feb 4, 2009 |
305 |
| Gilead Sciences Inc (Foster City CA), the biggest supplier of AIDS drugs in the US, said fourth-quarter earnings rose 41% on increased demand for its medicines. |
|
Brief article |
Feb 2, 2009 |
268 |
| Abbott Drug Pricing Condemned by AIDS Advocates in International Protests. |
|
|
Jan 28, 2009 |
1895 |
| A cocktail for disaster: how mismanagement, slothful government and a tight state budget killed a pioneering AIDS fund for Illinois' black communities. |
Virella, Kelly |
|
Jan 1, 2009 |
3208 |
| Good news in the fight against AIDS: from both medical and underwriting standpoints, HIV/AIDS has become a manageable disease. |
Hoehne, Brent; Swanson, Eric |
|
Dec 1, 2008 |
498 |
| Maturation inhibitors as new antiretroviral agents. |
Richards, John; McCallister, Scott |
Clinical report |
Dec 1, 2008 |
3133 |
